Homoeopathic medicines for treating bacterial tonsilitis

Role of Individualized Homoeopathic Medicines In Post-Streptococcal Sore Throat With Elevated Anti-Streptolysin O Antibody in Paediatric Age Group: A Single-Arm Pre-Post Interventional Trial - Nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/02/080607

Enrollment

Registered

2025-02-14

Start date

Unknown

Completion date

Unknown

Last updated

2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A409- Streptococcal sepsis, unspecified

Interventions

Intervention1: Individualised Homoeopathic Medicines.: Intervention is planned as administering indicated homoeopathic medicines in centesimal potencies (CH). Each dose will consist of 4 cane sugar gl

dosage and repetition depending upon the individual requirement of the cases. Patients will be advised to refrain from handling the globules or from eating, drinking, smoking or brushing teeth within

Eligibility

Inclusion criteria

Inclusion criteria: 1. Children suffering from sore throat of recent onset (more than 3 days), representing with clinical features of acute tonsillitis and bacterial aetiology confirmed by throat swab culture, and high ASO titre. 2. Participants of all sex. 3. Age between 5 and 15 years. 4. Literate patient s parents; ability to read and write in Bengali and/or English and /or Hindi. Illiterate participants will be interviewed by the investigators maintaining adequate privacy to fill up the scale or questionnaires. 5. The parents providing written informed consent voluntarily and the children providing with informed assent.

Exclusion criteria

Exclusion criteria: 1. Causes other than Bacterial. 2. Presence of uncontrolled co-morbidities. 3. Self-reported immune-compromised state. 4. Vulnerable population- Unconscious, non-ambulatory, too sick for consultation, terminally ill or critically ill patients, mentally incompetent people. 5. Simultaneous participation in any other clinical trials.

Design outcomes

Primary

Measure	Time frame
To detect the differences in serum anti streptolysin o antibody level in the paediatric age group with post-streptococcal sore throat after second and third months of treatment with individualised homoeopathic medicine.Timepoint: Day 0, month 2 and month 3	—

Secondary

Measure	Time frame
Visual Analogue Scale [ VASs] of sore throat pain model (STPM), namely pain VAS (STPIS), difficulty in swallowing VAS (DSS), and swollen throat VAS (swoTS)Timepoint: day 0, month 1, month 2, month 3;Modified Naranjo Criteria (MONARCH)Timepoint: Month 3	—

Countries

India

Contacts

Public ContactShishir Kumar Singh

National Institute of Homoeopathy

drshishirsinghmd@gmail.com7890321978

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026